Ultravist (Bayer HealthCare Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Ultravist drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Bayer HealthCare Pharmaceuticals Inc.
NON-PROPRIETARY NAME: iopromide
SUBSTANCE NAME: IOPROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
ROUTE: INTRA-ARTERIAL
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-12-30
END MARKETING DATE: 0000-00-00


Ultravist HUMAN PRESCRIPTION DRUG Details:

Item DescriptionUltravist from Bayer HealthCare Pharmaceuticals Inc.
LABELER NAME: Bayer HealthCare Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 498.72(mg/mL)
START MARKETING DATE: 2009-12-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50419-342_2489e7db-08dc-4023-8265-66e0424200ef
PRODUCT NDC: 50419-342
APPLICATION NUMBER: NDA021425

Other IOPROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bayer HealthCare Pharmaceuticals Inc.Ultravist